| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
| 06/10/1998 | EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 06/10/1998 | EP0846760A1 Production and use of anthelmintic agents and protective immunogens |
| 06/10/1998 | EP0846702A2 Soluble recombinant Alpha 5 Beta 3 adhesion receptor |
| 06/10/1998 | EP0846700A1 Pollen Allergens |
| 06/10/1998 | EP0846699A1 Substance wf16616, process for production thereof, and use thereof |
| 06/10/1998 | EP0846177A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 06/10/1998 | EP0846174A1 Methods for enhancing the production of interferon in cell culture |
| 06/10/1998 | EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/10/1998 | EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 06/10/1998 | EP0846164A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
| 06/10/1998 | EP0846160A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 06/10/1998 | EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same |
| 06/10/1998 | EP0767797A4 Plant peptide transport gene |
| 06/10/1998 | EP0733106A4 Plant arabinogalactan protein (agp) genes |
| 06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
| 06/10/1998 | EP0714403B1 Aqueous multiple-phase isolation of polypeptide |
| 06/10/1998 | EP0693131A4 Cell free system for protein synthesis and use of chaperone proteins therein |
| 06/10/1998 | EP0487627B1 Wound healing preparations containing heparanase |
| 06/10/1998 | EP0309569B1 Production of purified, biologically active, bacterially produced recombinant human csf-1 |
| 06/10/1998 | CN1184531A Method for diagnosing a patient for chlamydia |
| 06/10/1998 | CN1184484A Novel anti-AIDS immunotoxins |
| 06/10/1998 | CN1184158A Type 1V collagenase-resisting single stranded antibody |
| 06/10/1998 | CN1184114A Alpha derivative of human tumor necrosin and its preparation |
| 06/09/1998 | US5763748 Genetic engineered dna transforming plant cell to excrete human serum albumin |
| 06/09/1998 | US5763733 Antigen-binding fusion proteins |
| 06/09/1998 | US5763572 HTLV-II peptide antigens |
| 06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
| 06/09/1998 | US5763397 Glycopeptides, a process for their preparation and their use |
| 06/09/1998 | US5763393 Ability to bind n-methylasperate receptors; treatment fornervous system disorders |
| 06/09/1998 | US5763284 Methods for peptide synthesis and purification |
| 06/09/1998 | US5763274 Antibody 103B2 |
| 06/09/1998 | US5763256 Subtilisin-type serine protease having catalytic serine at or near amino terminus replaced by or converted to cysteine, specified proline replaced with different helix-forming amino acid |
| 06/09/1998 | US5763253 Methods of preparing tissue plasiminogen activator derivative composition |
| 06/09/1998 | US5763250 Chimeric toxins |
| 06/09/1998 | US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions |
| 06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
| 06/09/1998 | US5763243 Using a genetic engineered dna to repress the dominant negative gene |
| 06/09/1998 | US5763241 Insect resistant plants |
| 06/09/1998 | US5763223 DNA encoding a cytokine that induces apoptosis |
| 06/09/1998 | US5763214 Fibroblast growth factor 11 |
| 06/09/1998 | US5763213 Sensory and motor neuron derived factor (SMDF) |
| 06/09/1998 | US5763212 Binding low molecular mass cell penetrating ligand to protein |
| 06/09/1998 | US5763211 Polynucleotide which encodes receptor polypeptide |
| 06/09/1998 | US5763210 Recombinant production of interferon-gamma binding proteins |
| 06/09/1998 | US5763209 Methods and materials relating to the functional domains of DNA binding proteins |
| 06/09/1998 | US5763202 Medical diagnosis of prostate cancer; enzyme-linked immunosorbent assay |
| 06/09/1998 | US5763195 Method and compositions for making ACSF and ACSF antagonists |
| 06/09/1998 | US5763166 Gene associated with X linked Kallmann syndrome and diagnostic applications therefrom |
| 06/09/1998 | US5763164 Immunogenic cancer proteins and peptides and methods of use |
| 06/09/1998 | US5763161 Assay method of testing for the presence of cytomegalovirus antigen |
| 06/09/1998 | US5762939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| 06/09/1998 | US5762938 Modified recombinant vaccinia virus and expression vectors thereof |
| 06/09/1998 | US5762930 Bispecific reagents for redirected targeting of human lipoproteins |
| 06/09/1998 | US5762921 Composition and methods for the treatment of tumors |
| 06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 06/04/1998 | WO1998023775A2 Dna for evaluating the progression potential of cervical lesions |
| 06/04/1998 | WO1998023771A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection |
| 06/04/1998 | WO1998023762A2 Methods of producing a recombinant protein |
| 06/04/1998 | WO1998023761A1 HUMANIZED ANTI-CD11a ANTIBODIES |
| 06/04/1998 | WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 06/04/1998 | WO1998023759A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
| 06/04/1998 | WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 06/04/1998 | WO1998023750A2 Mammalian chemokines |
| 06/04/1998 | WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 06/04/1998 | WO1998023742A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES |
| 06/04/1998 | WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 06/04/1998 | WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/04/1998 | WO1998023735A1 Immune responses using compositions containing stress proteins |
| 06/04/1998 | WO1998023646A2 Binding agents specific for iga receptor |
| 06/04/1998 | WO1998023641A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 06/04/1998 | WO1998023631A1 Novel bacterial polypeptides and polynucleotides |
| 06/04/1998 | WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 06/04/1998 | WO1998023170A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof |
| 06/04/1998 | WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 06/04/1998 | CA2274313A1 Mammalian chemokines |
| 06/04/1998 | CA2272989A1 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
| 06/04/1998 | CA2272988A1 Methods of producing a recombinant protein |
| 06/04/1998 | CA2272847A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 06/04/1998 | CA2272536A1 Immune responses using compositions containing stress proteins |
| 06/04/1998 | CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 06/04/1998 | CA2271953A1 A novel cloned gaba-receptor subunit cdna sequence and stably co-transfected cell lines |
| 06/04/1998 | CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 06/04/1998 | CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 06/03/1998 | EP0845540A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same |
| 06/03/1998 | EP0845535A2 Leader peptidase (lep) from Streptococcus |
| 06/03/1998 | EP0845533A2 Keratin sulfate 6-sulfotransferase and DNA coding for the same |
| 06/03/1998 | EP0845530A2 Interferon gamma inducing factor |
| 06/03/1998 | EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library |
| 06/03/1998 | EP0845270A1 Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 06/03/1998 | EP0845044A1 Composition and its use |
| 06/03/1998 | EP0845038A1 Deuteriated substances |
| 06/03/1998 | EP0845037A1 Globulin protein 11s, usable as a seed impregnation marker during germination. |
| 06/03/1998 | EP0845006A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 06/03/1998 | EP0845005A1 Traf inhibitors |
| 06/03/1998 | EP0845004A1 Epitope tagging system |
| 06/03/1998 | EP0833834A4 Dna sequence and encoded mammary-specific breast cancer protein |
| 06/03/1998 | EP0580621B1 Nucleic acid fragment of the x chromosome region involved in the fragile x syndrome, nucleotide probe and method of diagnosing mental retardation with fragile x |
| 06/03/1998 | EP0358692B1 Cholera vaccines |
| 06/03/1998 | CN1183806A Polynucleotide immunogenic agents |